Carcinoembryonic antigen (CEA) has been a target for the development of CAR-T cells against gastric, colorectal, and breast cancers due to its overexpression in solid tumors when compared to normal cells [48]. This evidence concerns the gene CEACAM5 and breast carcinoma.